Marc D. Kozin - 01 Jan 2023 Form 3 Insider Report for Vascular Biogenics Ltd.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
03 Jan 2023, 20:21:04 UTC
Prior SEC filing
10 Jun 2022
Next SEC filing
10 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Samuel Backenroth, Attorney-in-Fact

Key filing fact

Marc D. Kozin filed Form 3 for Vascular Biogenics Ltd. on 03 Jan 2023.

Key facts

  • This page summarizes Marc D. Kozin's Form 3 filing for Vascular Biogenics Ltd..
  • 0 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 03 Jan 2023, 20:21.

Change

  • Previous filing in this sequence was filed on 10 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VBLT holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
39,000
Date
01 Jan 2023
Ownership
By Marc D. Kozin Irrevocable Trust
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jan 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
50,000
Exercise price
$3.30
Footnotes
F2
VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jan 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
125,000
Exercise price
$1.17
Footnotes
F3
VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jan 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
125,000
Exercise price
$2.38
Footnotes
F4
VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jan 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
79,406
Exercise price
$2.31
Footnotes
F5
VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jan 2023
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
52,937
Exercise price
$2.12
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

These shares are held by the Marc D. Kozin Irrevocable Trust, of which the Reporting Person's spouse is one of the beneficiaries. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any.

Footnote F2

These options were granted on 05/05/16 under the Issuer's Employee Share Ownership and Option Plan (2014) (the "2014 Plan") and are fully vested and exercisable.

Footnote F3

These options were granted on 11/24/20 under the 2014 Plan, with 25% of the shares underlying these options vesting on November 24, 2021 (the one year anniversary of the grant date), and the remainder vesting quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.

Footnote F4

These options were granted on 07/20/21 under the 2014 Plan, with 25% of the shares underlying these options vesting on July 20, 2022 (the one year anniversary of the grant date), and the remainder vesting quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.

Footnote F5

These options were granted on 12/07/21 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.

Footnote F6

These options were granted on 01/02/22 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .